Piezo1 Knockout MLO-Y4 Cell Line

The Piezo1 Knockout MLO-Y4 Cell Line is a CRISPR/Cas9-edited knockout cell line designed for the targeted disruption of the mouse Piezo1 gene. This loss-of-function model eliminates Piezo1 expression, providing a defined genetic system to dissect mechanosensitive signaling in osteocyte biology. The cell line serves as a stable, renewable resource for investigating the role of Piezo1 in mechanotransduction and calcium-dependent pathways without relying on transient gene silencing methods.

The host cell line, MLO-Y4, is a well-characterized murine osteocyte-like cell line originally derived from long bone tissue and immortalized via SV40 large T-antigen under the osteocalcin promoter. These cells retain many properties of primary osteocytes, including a dendritic morphology, expression of osteocyte markers, and the ability to respond to mechanical stimuli. As a bone-embedded mechanosensory cell type, MLO-Y4 cells are central to studies of bone remodeling, mineral homeostasis, and the cellular responses to fluid shear stress and substrate strain.

Piezo1 encodes a mechanosensitive non-selective cation channel that opens in response to membrane tension, enabling rapid calcium influx. In osteocytes, this calcium entry triggers downstream effectors such as calmodulin, calcineurin, NFAT, and the Hippo pathway components YAP/TAZ. Mechanistically, Piezo1 is activated by mechanical forces including shear stress and stretch, and its signaling converges on the regulation of key bone-remodeling factors, notably RANKL and OPG. The channel physically interacts with STOML3 and cytoskeletal elements, integrating mechanical cues with MAPK/ERK and integrin signaling to modulate gene expression programs that control osteoclastogenesis and bone mass.

Given the central role of MLO-Y4 osteocytes in sensing and transducing mechanical loads, the Piezo1 knockout in this background directly addresses the molecular basis of bone mechanotransduction. Disruption of Piezo1 in these cells allows researchers to delineate how mechanical signals are converted into biochemical responses that influence bone formation and resorption. This model is particularly relevant for osteoporosis and other bone-loss conditions where mechanosensitivity is compromised, as it enables the dissection of Piezo1-dependent versus -independent pathways in the regulation of RANKL/OPG balance and subsequent osteoclast activity.

The Piezo1 Knockout MLO-Y4 Cell Line supports a broad range of experimental applications, from basic mechanobiology to translational bone research. Typical workflows include calcium imaging under fluid shear stress, YAP nuclear translocation assays, RANKL/OPG ELISA quantification, and osteoclast differentiation co-cultures to assess functional outcomes. The line is also suitable for RNA-seq and proteomic profiling to map global signaling changes, as well as for screening potential anabolic agents that bypass or restore Piezo1-mediated signaling. For further information and technical support, please contact Ascent Research.